Corante

About this Author
Derek Lowe
Derek Lowe, an Arkansan by birth, got his BA from Hendrix College and his PhD in organic chemistry from Duke before spending time in Germany on a Humboldt Fellowship on his post-doc. He's worked for several major pharmaceutical companies since 1989 on drug discovery projects against schizophrenia, Alzheimer's, diabetes, osteoporosis and other diseases. To contact Derek email him directly: derekb.lowe@gmail.com Twitter: Dereklowe

Chemistry and Drug Data: Drugbank
Emolecules
ChemSpider
Chempedia Lab
Synthetic Pages
Organic Chemistry Portal
PubChem
Not Voodoo
DailyMed
Druglib
Clinicaltrials.gov

Chemistry and Pharma Blogs:
Org Prep Daily
The Haystack
MedChem Buzz
Kilomentor
On Pharma
A New Merck, Reviewed
Liberal Arts Chemistry
One in Ten Thousand
Electron Pusher
Periodic Tabloid
All Things Metathesis
C&E News Blog
Propter Doc
Chemiotics II
The Chemical Notebook
Chemical Space
Noel O'Blog
In Vivo Blog
Terra Sigilatta
Chirality
BBSRC/Douglas Kell
ChemBark
Drug Discovery Opinion
Realizations in Biostatistics
Chemjobber
Pharmalot
WSJ Health Blog
ChemSpider Blog
Pharmagossip
Med-Chemist
Organic Chem - Education & Industry
Useful Chemistry
Chiral Jones
Pharma Strategy Blog
No Name No Slogan
Practical Fragments
SimBioSys
The Curious Wavefunction
Natural Product Man
Totally Synthetic
Fragment Literature
The F- Blog
Chemistry World Blog
Synthetic Nature
Chemistry Blog
Synthesizing Ideas
Carbon-Based Curiosities
Experimental Error
Business|Bytes|Genes|Molecules
Eye on FDA
Sigma-Aldrich ChemBlogs
Chemical Forums
Depth-First
Symyx Blog
P212121
ChemCafe
Sceptical Chymist
Lamentations on Chemistry
Computational Organic Chemistry
Mining Drugs
Henry Rzepa


Science Blogs and News:
Bad Science
The Loom
Uncertain Principles
Fierce Biotech
Blogs for Industry
Omics! Omics!
Young Female Scientist
Notional Slurry
Nobel Intent
SciTech Daily
Science Blog
FuturePundit
Aetiology
Gene Expression (I)
Gene Expression (II)
Sciencebase
Pharyngula
Adventures in Ethics and Science
Transterrestrial Musings
Slashdot Science
A Scientist's Life
Speculist
Cosmic Variance
The Capsule
Zeroth Order Approximation
Biology News Net


Medical Blogs
Med Tech Sentinel
DB's Medical Rants
Science-Based Medicine
GruntDoc
The Health Care Blog
Respectful Insolence
Black Triangle
Diabetes Mine


Economics and Business
Marginal Revolution
Arnold Kling
The Volokh Conspiracy
Knowledge Problem
The Stalwart


Politics / Current Events
Virginia Postrel
Tinkerty Tonk
Instapundit
Megan McArdle
Mickey Kaus
Colby Cosh
Alien Corn
No Watermelons


Belles Lettres
Two Blowhards
Critical Mass
Arts and Letters Daily
God of the Machine
Armavirumque
About Last Night
In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

In the Pipeline

« Colors May Fade | Main | Anything Worth Doing. . . »

April 22, 2002

Fun While It Lasted

Email This Entry

Posted by Derek

The realization has gradually crept up on pharmaceutical chemists that the Great Hiring Wave of the last few years is over. For a while there, it was the biggest one ever. It swept in plenty of people fresh out of grad school, and probably decreased the percent of PhDs doing post-docs, since the offers were good whether you did one or not. It also allowed lots of experienced people to jump companies (and here's where I raise my hand, since that's what I did.)

Some history: there last was a noticable hiring phase in the industry in the late 1980s and early 1990s (which, fortunately, is when I was looking for my first job after my own post-doc.) It wasn't anything like what we've just finished, but my impression is that 1986-1991 or so wasn't bad, either. All this came to a screeching halt with the political fights over the Clinton health care proposals. 1993 and 1994 were absolutely terrible years to get a job in the drug industry. Everyone was pulling back and battening down the hatches. 1995 and 1996 returned to somewhat normal levels.

But around 1997, things really began to roll. Several large companies began hiring more aggressively as they expanded their facilities. There was a building boom going on across the industry, and those new labs had to get filled up. Salary offers increased for new hires, and the headhunters began to ring the phones of experienced chemists with some pretty good offers, too (which is what happened to me.) Things kept on hopping for the next two or three years.

I should go back and count ad pages in Chemical and Engineering News to prove this, but I think that last year there was a noticable slowing down. And this year, with all the worries that companies have about their R&D pipelines, there's no doubt about it. My sympathies to those organic chemists who are just finished up degress or post-doc appointments and are ready to hit the interview trail; it's going to be harder (though not impossible.) It's not like 93-94, fortunately. But it's not 1998 any more, either.

Comments (0) + TrackBacks (0) | Category: Drug Industry History


COMMENTS

EMAIL THIS ENTRY TO A FRIEND

Email this entry to:

Your email address:

Message (optional):




RELATED ENTRIES
Academia and Industry, Suing Each Other
Let's Start Off the Meeting With An Ad, OK?
The Academic-Industrial Collaboration in Drug Discovery Panel: Today
Glass Structure, Atom by Atom
How the Andrulis Paper Got Published
AstraZeneca in Waltham
Fluorine NMR: Why Not?
AstraZeneca Layoffs and Closings